| Name | Title | Contact Details |
|---|
D&G Machine Products is a Westbrook, ME-based company in the Business Services sector.
Axsa Document Solutions, Inc. is a provider of office technology solutions. We sell and provide contract services for automated office equipment, including digital black and white copiers, color copiers, facsimile equipment, printers, scanners and
Sprinklr is an American software company focused on customer experience management (CXM). Founded in September 2009 by Ragy Thomas and headquartered in New York City, Sprinklr has evolved from a social media management platform into a comprehensive CXM solution. The company offers an AI-powered platform that integrates four main product suites: Sprinklr Service for customer care, Sprinklr Social for social media marketing, Sprinklr Marketing for content management and advertising, and Sprinklr Insights for analytics and research. Sprinklr serves many leading enterprise brands, helping them unify customer experiences across more than 30 digital channels. The company went public on the New York Stock Exchange in June 2021 and reported a revenue of $618.2 million for the fiscal year ending 2023. With a global workforce of approximately 3,245 employees, Sprinklr continues to innovate in the CXM sector under the leadership of CEO Rory Read.
CARB-X (Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator) is a global non-profit partnership dedicated to accelerating early development antibacterial R&D to address the rising global threat of drug-resistant bacteria. CARB-X is led by Boston University and its funding is provided by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the U.S. Department of Health and Human Services; the Wellcome Trust, a global charity based in the UK; Germanys Federal Ministry of Education and Research (BMBF); the UK Department of Health and Social Cares Global Antimicrobial Resistance Innovation Fund (UK GAMRIF); the Bill & Melinda Gates Foundation, and with in-kind support from National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health (NIH) within the HHS. CARB-X is investing more than $500 million from 2016-2021 to support innovative antibiotics and other therapeutics, vaccines and rapid diagnostics. CARB-X supports the worlds largest and most innovative pipeline of preclinical products against drug-resistant infections. CARB-X focuses exclusively on high priority drug-resistant bacteria, especially Gram-negatives. CARB-X is headquartered at Boston University School of Law.